Patent Assignment
Reel/Frame 030804/0429
Assignment of Assignor's Interest
Recorded: 2013-07-16
Pages: 8
Assignor
ABBOTT GMBH & CO KG
Executed: 2012-11-01
Assignee
ABBVIE DEUTSCHLAND GMBH & CO KG
MAX-PLANCK-RING 2A, WIESBADEN, 65205, GERMANY
Covered Properties
(60)
1,2,4-Triazolo[4,3-B]Pyridazine Derivatives and Their Use
Patent:
5,905,079 →
Application:
08/930,864 →
Piperazine Derivatives as Therapeutic Agents
Patent:
6,114,334 →
Application:
08/973,843 →
Heterocyclcarboxamide Deritvatives and Their Use as Therapeuctic Agents
Patent:
5,935,973 →
Application:
08/981,671 →
Heteroarylcarboxamide Derivatives for Treating Cns Disorders
Patent:
6,107,310 →
Application:
09/091,129 →
Use of 2-(2-Morpholinophenyl) Guanidine Derivatives for the Treatment of Diabetes Complications
Patent:
6,133,267 →
Application:
09/319,881 →
Heteroarylsulfonamide Derivatives and Pharmaceutical Compositions Containing Them
Patent:
6,218,405 →
Application:
09/331,064 →
Sulfonamide Compounds Having 5-Ht Receptor Activity
Patent:
6,136,825 →
Application:
09/331,066 →
Human NESP55 Polypeptides, Polynucleotides and Uses Thereof
Patent:
6,608,025 →
Application:
09/468,554 →
Therapeutic Agents
Patent:
6,974,840 →
Application:
10/019,802 →
Tetrahydrobenzazepines and Their Use in the Modulation of the Dopamine D3 Receptor
Guanidine Compounds, and Use Thereof as Binding Partners for 5-HT5 Receptors
Cellular RhoGTPase activation assay
Application:
11/332,680 →
Publication:
US 2006/0177816
Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor
Pyrimidine Compounds and Use Thereof
Substituted Oxindol Derivatives and Medicaments Containing the Same
4-Piperazinyl-Pyrimidine Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Aminomethyl Substituted Bicyclic Aromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Aminoethylaromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Heterocyclic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
6-Amino(Aza)Indane Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Azabicycloheptyl Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the Dopamine D3 receptor
Therapeutic Agents
Triazole Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Substituted N-Heterocyclic Compounds and Their Use as Dopamine D3 Receptor Ligands
Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
Application:
11/794,582 →
Publication:
US 2012/0115842
AGER-Peptides and Use Thereof
Production of Dosage Forms Comprising a Solid Dispersion of a Microcrystalline Agent
Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix
Application:
11/922,609 →
Publication:
US 2009/0220596
Pyridazine Compounds as Glycogen Synthase Kinase 3 Inhibitors
Pyrimidine Compounds and Use Thereof
Substituted Oxindole Derivatives, Drugs Containing Said Derivatives and the Use Thereof
Heterocyclic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Guanidine Compounds, and Use Thereof as Binding Partners for 5-HT5 Receptors
Pyridin-2-One Compounds and Their Use as Modulators of the Dopamine D3 Receptor
Substituted Oxindol Derivatives and Medicaments Containing the Same
Melt-Extruded Solid Dispersions Containing an Apoptosis-Inducing Agent
Application:
13/253,727 →
Publication:
US 2012/0108590
Benzenesulfonyl or Sulfonamide Compounds Suitable for Treating Disorders That Respond to the Modulation of the Serotonin 5-HT6 Receptor
N-Phenyl-(Homo)Piperazinyl-Benzenesulfonyl or Benzenesulfonamide Compounds Suitable for Treating Disorders That Respond to the Modulation of the Serotonin 5-HT6 Receptor
Method for Producing Monolithic Tablets
Nampt and Rock Inhibitors
Triazole Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Application:
13/333,702 →
Publication:
US 2012/0095015
Aminoethylaromatic Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Application:
13/405,646 →
Publication:
US 2012/0220635
Benzazepine Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Novel Inhibitor Compounds of Phosphodiesterase Type 10A
Aminochromane, Aminothiochromane and Amino-1,2,3,4-Tetrahydroquinoline Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Substituted Isoquinolines and Phthalazines as Inhibitors of Phosphodiesterase Type 10A
Novel Inhibitor Compounds of Phosphodiesterase Type 10A
Application:
13/672,438 →
Publication:
US 2013/0116229
Novel Inhibitor Compounds of Phosphodiesterase Type 10A
Application:
61/557,874 →
Novel Inhibitor Compounds of Phosphodiesterase Type 10A
Application:
61/557,878 →
N-Substituted Aminobenzocycloheptene, Aminotetraline, Aminoindane and Phenalkylamine Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Application:
61/561,653 →
Composition and Method for the Diagnosis and Treatment of Iron-Related Disorders
Application:
61/570,499 →
Composition and Method for the Diagnosis and Treatment of Iron-Related Disorders
Application:
61/570,715 →
Composition and Method for the Diagnosis and Treatment of Iron-Related Disorders
Application:
61/578,122 →
Composition and Method for the Diagnosis and Treatment of Diseases Associated with Neurite Degeneration
Application:
61/591,324 →
N-Substituted Aminobenzocycloheptene, Aminotetraline, Aminoindane and Phenalkylamine Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Application:
61/597,887 →
Isoindoline Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Application:
61/598,083 →
Novel Inhibitor Compounds of Phosphodiesterase Type 10A
Application:
61/684,290 →
Acylaminocycloalkyl Compounds Suitable for Treating Disorders That Respond to Modulation of Dopamine D3 Receptor
Application:
61/716,824 →
Isoindoline Derivatives, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Application:
61/719,647 →
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Corrective Assignment to Correct the Assignee Address. Document Previously Recorded on Reel 013758 Frame 0551, Assignor Confirms the Assignment of the Entire Interest.
Sep 9, 2003
From: KNOLL AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 014455/0058 →
Assignment of Assignor's Interest
Apr 19, 2006
From: TEUSCH, NICOLE; MEZLER, MARIO
To: ABBOTT GMBH & CO. KG
Reel/Frame 017774/0365 →
Assignment of Assignor's Interest
Jun 14, 2007
From: NETZ, ASTRID; AMBERG, WILHELM; LANGE, UDO; OCHSE, MICHAEL
To: ABBOTT GMBH & CO., KG
Reel/Frame 019819/0707 →
Assignment of Assignor's Interest
Sep 10, 2007
From: GENESTE, HERVE; BRAJE, WILFRIED; HAUPT, ANDREAS
To: ABBOTT GMBH & CO. KG
Reel/Frame 019860/0319 →
Assignment of Assignor's Interest
Sep 24, 2007
From: DRESCHER, KARLA; HAUPT, ANDREAS; UNGER, LILIANE; TURNER, SEAN C
To: ABBOTT GMBH & CO., KG
Reel/Frame 019952/0563 →
Assignment of Assignor's Interest
Sep 24, 2007
From: DRESCHER, KARLA; HAUPT, ANDREAS; UNGER, LILIANE; TURNER, SEAN C.
To: ABBOTT GMBH & CO. KG
Reel/Frame 019907/0384 →
Assignment of Assignor's Interest
Sep 24, 2007
From: DRESCHER, KARLA; HAUPT, ANDREAS; UNGER, LILIANE; TURNER, SEAN C.
To: ABBOTT GMBH & CO. KG
Reel/Frame 019952/0526 →
Assignment of Assignor's Interest
Nov 19, 2007
From: GENESTE, HERVE; HAUPT, ANDREAS; BRAJE, WILFRIED; LUBISCH, WILFRIED
To: ABBOTT GMBH & CO. KG
Reel/Frame 020216/0003 →
Assignment of Assignor's Interest
Nov 23, 2007
From: DRESCHER, KARLA; HAUPT, ANDREAS; UNGER, LILIANE; TURNER, SEAN C.
To: ABBOTT GMBH & CO., KG
Reel/Frame 020216/0206 →
Assignment of Assignor's Interest
Mar 12, 2008
From: LUBISCH, WILFRIED; OOST, THORSTEN; WERNET, WOLFGANG; UNGER, LILIANE
To: ABBOTT GMBH & CO. KG
Reel/Frame 020965/0887 →
Assignment of Assignor's Interest
Dec 12, 2008
From: BRAJE, WILFRIED; HAUPT, ANDREAS; LUBISCH, WILFRIED; GRANDEL, ROLAND
To: ABBOTT GMBH & CO. KG
Reel/Frame 021970/0592 →
Assignment of Assignor's Interest
May 20, 2009
From: HAUPT, ANDREAS; UNGER, LILIANE; DRESCHER, KARLA; JONGEN-RELO, ANA LUCIA
To: ABBOTT GMBH & CO. KG
Reel/Frame 022713/0340 →